TY - JOUR
T1 - Authentication of patients and participants in health information exchange and consent for medical research
T2 - A key step for privacy protection, respect for autonomy, and Trustworthiness
AU - Kogetsu, Atsushi
AU - Ogishima, Soichi
AU - Kato, Kazuto
N1 - Funding Information:
We thank Melissa Leffler, MBA, and Peter Fogarty, MA English 1st Class, from Edanz Group (www.edanzediting.com/ac) for editing different versions of this manuscript. This work was partly supported by JSPS KAKENHI Grant Number 17K19812 to KK.
Publisher Copyright:
© 2018 Kogetsu, Ogishima and Kato.
PY - 2018/6/1
Y1 - 2018/6/1
N2 - Genome and other data are already being used in areas including cancer and rare diseases. Data-sharing and secondary uses are likely to become much broader and far more extensive; thus, obtaining proper consent for these new uses of data is an important issue. Obtaining consent through online methods may be an option to overcome the problems associated with one-off, paper-based informed consent. When the process of obtaining consent takes place remotely, authentication must be assured. Patients may also choose to store some of their own information online, such as genetic information, and allow healthcare professionals to access this data. In this health information transfer and exchange process, it is vital that anyone accessing this information be correctly authenticated to protect patients' privacy. In this article, we first clarified that authentication has two roles: i.e., not only to prevent impersonation but also to prove intent, which is a vital step to ensure that medical research and health information exchange are conducted ethically. We then set out methods of authentication. As a result, we were able to make suggestions about the requirements for authentication and a possible method of authentication for these purposes. We considered problems of biometrics and recommended two-factor authentication without biometrics as a workable solution. However, three-factor authentication including biometrics seems likely to be used once biometrics become more common.
AB - Genome and other data are already being used in areas including cancer and rare diseases. Data-sharing and secondary uses are likely to become much broader and far more extensive; thus, obtaining proper consent for these new uses of data is an important issue. Obtaining consent through online methods may be an option to overcome the problems associated with one-off, paper-based informed consent. When the process of obtaining consent takes place remotely, authentication must be assured. Patients may also choose to store some of their own information online, such as genetic information, and allow healthcare professionals to access this data. In this health information transfer and exchange process, it is vital that anyone accessing this information be correctly authenticated to protect patients' privacy. In this article, we first clarified that authentication has two roles: i.e., not only to prevent impersonation but also to prove intent, which is a vital step to ensure that medical research and health information exchange are conducted ethically. We then set out methods of authentication. As a result, we were able to make suggestions about the requirements for authentication and a possible method of authentication for these purposes. We considered problems of biometrics and recommended two-factor authentication without biometrics as a workable solution. However, three-factor authentication including biometrics seems likely to be used once biometrics become more common.
KW - Authentication
KW - Biometrics
KW - Consent
KW - Data sharing
KW - EHealth
KW - Health information exchange
KW - Rare disease
KW - Secondary use
UR - http://www.scopus.com/inward/record.url?scp=85048288959&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048288959&partnerID=8YFLogxK
U2 - 10.3389/fgene.2018.00167
DO - 10.3389/fgene.2018.00167
M3 - Article
AN - SCOPUS:85048288959
SN - 1664-8021
VL - 9
JO - Frontiers in Genetics
JF - Frontiers in Genetics
IS - JUN
M1 - 167
ER -